Neurogene
NGNE
NGNE
87 hedge funds and large institutions have $368M invested in Neurogene in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
+1
Holders Change %
+1.16%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
30
Reduced
17
Closed
25
Calls
$3.06M
Puts
$5.52M
Net Calls
-$2.45M
Net Calls Change
-$2.45M
Top Buyers
| 1 |
CC
1
Casdin Capital
New York
|
$29.6M |
| 2 |
CC
2
Commodore Capital
New York
|
$18.3M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$11M |
| 4 |
SB
4
Samsara BioCapital
Palo Alto,
California
|
$39.3M |
| 5 |
DM
5
Deerfield Management
New York
|
$10.2M |
